Beyond Statins: Bempedoic Acid, Inclisiran & Lp(a)

Beyond Statins: Bempedoic Acid, Inclisiran & Lp(a)

Tuesday, December 1st 2026 - 3:30 PM (IST)

10 days to go

12 doctors attending

Tuesday, December 1st 2026 - 3:30 PM (IST)

Medflix

About this session

Despite the widespread use of statins, many patients continue to have elevated LDL cholesterol and residual cardiovascular risk. Emerging lipid-lowering therapies are expanding the options available for managing dyslipidaemia and reducing cardiovascular risk.

This session will explore the evolving role of bempedoic acid and inclisiran in lipid management, alongside the clinical significance of lipoprotein(a) [Lp(a)] as an independent cardiovascular risk factor. It will discuss their mechanisms of action, clinical evidence, patient selection and practical considerations in clinical practice.

Join us for an expert-led discussion on the latest advances in lipid management and the future of cardiovascular risk reduction beyond statins.

Faculty

Other details

Registration

Free

Duration

60 min

Replay

Yes

Certificate

No

Language

English

Explore other sessions

Emergency approach to acute Kidney injury

Emergency approach to acute Kidney injury

23 November 2026 | 2:30 PM (IST)